Original Article| Volume 12, ISSUE 1, P70-77, January 2018

Download started.


Comparison of the effects of flaxseed oil and sunflower seed oil consumption on serum glucose, lipid profile, blood pressure, and lipid peroxidation in patients with metabolic syndrome

Published:November 20, 2017DOI:


      • Flaxseed can be effective in amelioration of some symptoms of metabolic syndrome.
      • Flaxseed oil consumption may decrease blood pressure and lipid peroxidation.
      • Flaxseed is one of the major vegetal sources of essential omega-3 fatty acids.
      • Sunflower seed oil is one of the most consumed sources of polyunsaturated fatty acids in the world.


      Metabolic syndrome (MetSyn) increases the risk of type II diabetes and morbidity and mortality due to cardiovascular diseases. Flaxseed oil (FO), as a functional food, is one of the major vegetal sources of essential omega-3 fatty acids.


      This study aimed to compare the effects of consumption of FO and sunflower seed oil (SO) on lipid peroxidation and other symptoms of MetSyn.


      This randomized controlled interventional trial was conducted on 60 volunteers aged 30 to 60 years who were diagnosed with MetSyn in Shiraz, Iran. The participants who fulfilled the inclusion criteria were randomly assigned to SO (n = 30, receiving 25 mL/d SO) and FO (n = 30, receiving 25 ml/d FO) groups using block randomization. The diets were identical for all the participants. Blood pressure (BP), serum lipid, fasting blood sugar, and malondialdehyde were measured at baseline and at the end of week 7.


      The results showed no significant difference between the 2 groups regarding blood lipid levels and fasting blood sugar at the end of the study. However, significant reductions in total cholesterol, low-density lipoprotein cholesterol (5.6% in FO and 10.8% in SO), and triglyceride levels were seen within each group after treatment with FO and SO (P < .05). Nonetheless, between-group changes were significant (<0.05) for systolic BP (mean [±standard deviation {SD}] changes were −14.0 ± 22.41 in the FO group [P = .004] and 0.92 ± 8.70 in the SO group [P = .594]) and diastolic BP (mean [±SD] changes were −4.26 ± 7.44 in the FO group [P = .007] and 1.30 ± 6.91 in the SO group [P = .344]), but marginally significant (P = .053) for malondialdehyde level (mean [±SD] changes were −1.29 ± 1.48 in the FO group [P < .001] and −0.52 ± 1.34 in the SO group [P = .52]). A significant decrease in weight was also found in both groups. However, waist circumference decreased significantly only in the FO group at the end of the study (P < .05).


      Our results indicated that dietary FO could be effective in amelioration of some symptoms of MetSyn and decrease BP and lipid peroxidation.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Clinical Lipidology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • McNeal C.
        • Wilson D.P.
        Metabolic syndrome and dyslipidemia in youth.
        J Clin Lipidol. 2008; 2: 147-155
        • Toth P.
        • Henriksson K.M.
        • Palmer M.K.
        Metabolic syndrome and low-density lipoprotein cholesterol goal attainment in the national health and nutrition examination survey (2003-2012).
        J Clin Lipidol. 2016; 10: 721-722
        • Tarantino G.
        • Finelli C.
        What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?.
        World J Gasteroenterol. 2013; 19: 3375-3384
        • Kaur J.
        A comprehensive review on metabolic syndrome.
        Cardiol Res Pract. 2014; 2014: 943162
        • Poudyal H.
        • Panchal S.K.
        • Diwan V.
        • Brown L.
        Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action.
        Prog Lipid Res. 2011; 50: 372-387
        • Bloedon M.
        • Szapary P.O.
        Flaxseed and cardiovascular risk.
        Nutr Rev. 2004; 62: 18-27
        • Mirmiran P.
        • Hosseinpour-Niazi S.
        • Naderi Z.
        • Bahadoran Z.
        • Sadeghi M.
        • Azizi F.
        Association between interaction and ratio of ω-3 and ω-6 polyunsaturated fatty acid and the metabolic syndrome in adults.
        Nutrition. 2012; 28: 856-863
        • Lands B.
        Dietary omega-3 and omega-6 fatty acids compete in producing tissue compositions and tissue responses.
        Mil Med. 2014; 179: 76-81
        • Mayneris-Perxachs J.
        • Guerendiain M.
        • Castellote I.
        • et al.
        Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease.
        Clin Nutr. 2014; 33: 90-97
        • Holvoet P.
        • De Keyzer D.
        • Jacobs Jr., D.R.
        Oxidized LDL and the metabolic syndrome.
        Future Lipidol. 2008; 3: 637-649
        • Khattab R.Y.
        • Zeitoun M.A.
        Quality evaluation of flaxseed oil obtained by different extraction techniques.
        LWT Food Sci Technol. 2013; 53: 338-345
        • O'Brien R.D.
        Fat and Oil Formulating and Processing for Application.
        3rd ed. CRC Press, Boca Raton, FL2008 (ISBN 9781420061666-CAT# 61666)
        • Melanson E.L.
        • Astrup A.
        • Donahoo W.T.
        The relationship between dietary fat and fatty acid intake and body weight diabetes, and the metabolic syndrome.
        Ann Nutr Metab. 2009; 55: 229-243
        • National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
        Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
        Circulation. 2002; 106: 3143-3421
        • Halliwell B.
        • Chirico S.
        Lipid peroxidation: its mechanism, measurement, and significance.
        Am J Clin Nutr. 1993; 57 (discussion 724S-725S): 715S-724S
        • Al-Khudairy L.
        • Hartley L.
        • Clar C.
        • Flowers N.
        • Hooper L.
        • Rees K.
        Omega 6 fatty acids for the primary prevention of cardiovascular disease.
        Cochrane Database Syst Rev. 2015; : CD011094
        • Paschos G.K.
        • Magkos F.
        • Panagiotakos D.B.
        • Votteas V.
        • Zampelas A.
        Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients.
        Eur J Clin Nutr. 2007; 61: 1201-1206
        • Berry E.M.
        • Hirsch J.
        Does dietary linolenic acid influence blood pressure?.
        Am J Clin Nutr. 1986; 44: 336-340
        • Khalesi S.
        • Irwin C.
        • Schubert M.
        Flaxseed consumption may reduce blood pressure: a systematic review and meta-analysis of controlled trials.
        J Nutr. 2015; 145: 758-765
        • Ursoniu S.
        • Sahebkar A.
        • Andrica F.
        • Serban C.
        • Banach M.
        • LBPMC Group
        Effects of flaxseed supplements on blood pressure: a systematic review and meta-analysis of controlled clinical trial.
        Clin Nutr. 2016; 35: 615-625
        • Das U.N.
        Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules.
        Lipids Health Dis. 2008; 7: 37
        • Martínez-Clemente M.
        • Clària J.
        • Titos E.
        The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
        Curr Opin Clin Nutr Metab Care. 2011; 14: 347-353
        • Pickens C.A.
        • Sordillo L.M.
        • Zhang C.
        • Fenton J.I.
        Obesity is positively associated with arachidonic acid-derived 5- and 11-hydroxyeicosatetraenoic acid (HETE).
        Metabolism. 2017; 70: 177-191
        • Micallef M.
        • Munro I.
        • Phang M.
        • Garg M.
        Plasma n-3 Polyunsaturated Fatty Acids are negatively associated with obesity.
        Br J Nutr. 2009; 102: 1370-1374
        • Cardel M.
        • Lemas D.J.
        • Jackson K.H.
        • Friedman J.E.
        • Fernández J.R.
        Higher intake of PUFAs is associated with lower total and visceral adiposity and higher lean mass in a racially diverse sample of children.
        J Nutr. 2015; 145: 2146-2152
        • Ooi E.M.
        • Watts G.F.
        • Ng T.W.
        • Barrett P.H.
        Effect of dietary fatty acids on human lipoprotein metabolism: a comprehensive update.
        Nutrients. 2015; 7: 4416-4425
        • El-Waseif M.A.
        • Abd El-Dayem H.H.
        • Hashem H.A.
        • El-Behairy S.A.
        Hypolipidemic effect of fat spreads containing flaxseed oil.
        Ann Agric Sci. 2014; 59: 17-24
        • Kawakami Y.
        • Yamanaka-Okumura H.
        • Naniwa-Kuroki Y.
        • Sakuma M.
        • Taketani Y.
        • Takeda E.
        Flaxseed oil intake reduces serum small dense low-density lipoprotein concentrations in Japanese men: a randomized, double blind, crossover study.
        Nutr J. 2015; 14: 39
        • Gillingham L.G.
        • Gustafson J.A.
        • Han S.Y.
        • Jassal D.S.
        • Jones P.J.
        High-oleic rapeseed (canola) and flaxseed oils modulate serum lipids and inflammatory biomarkers in hypercholesterolaemic subjects.
        Br J Nutr. 2011; 105: 417-427
        • Zhao G.
        • Etherton T.D.
        • Martin K.R.
        • West S.G.
        • Gillies P.J.
        • Kris-Etherton P.M.
        Dietary a-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women.
        J Nutr. 2004; 134: 2991-2997
        • Wilkinson P.
        • Leach C.
        • Ah-Sing E.E.
        • et al.
        Influence of alpha-linolenic acid and fish-oil on markers of cardiovascular risk in subjects with anatherogenic lipoprotein phenotype.
        Atherosclerosis. 2005; 181: 115-124
        • Ayala A.
        • Munoz M.F.
        • Arguelles S.
        Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal.
        Oxid Med Cell Longev. 2014; 2014: 360435
        • Pignatelli P.
        • Sanguigni V.
        • Lenti L.
        • et al.
        Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin.
        J Thromb Haemost. 2007; 5: 1170-1178
        • Makni M.
        • Fetoui H.
        • Gargouri N.K.
        • et al.
        Hypolipidemic and hepatoprotective effects of flax and pumpkin seed mixture rich in omega-3 and omega-6 fatty acids in hypercholesterolemic rats.
        Food Chem Toxicol. 2008; 46: 3714-3720
        • Shousha W.G.
        • El-mezayen H.A.
        • Abdu-Halim S.H.S.
        • Mohmmed E.A.
        Antioxidant EFFECT of Flaxseed against liver Cirrhosis induced in Thioacetamide intoxicated rats.
        Egypt J Hosp Med. 2013; 51: 448-460